{
  "actions": [
    {
      "acted_at": "2001-11-06", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [
        {
          "reference": "CR S11489-11491", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1635-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Frist, William H.", 
      "sponsored_at": "2001-11-16", 
      "state": "TN", 
      "thomas_id": "01336", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Gregg, Judd", 
      "sponsored_at": "2001-11-06", 
      "state": "NH", 
      "thomas_id": "00466", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-11-06", 
  "number": "1635", 
  "official_title": "A bill to ensure the prompt research, development, manufacture, and distribution of new life-saving drugs, biologics, and medical devices that prevent or mitigate the consequences of a chemical or biological bioterrorist attack, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Pathogen Research, Emergency Preparedness and Response Efforts Act of 2001", 
  "sponsor": {
    "district": null, 
    "name": "Hutchinson, Tim", 
    "state": "AR", 
    "thomas_id": "00578", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-11-06", 
  "subjects": [
    "Academic medical centers", 
    "Administrative procedure", 
    "Animals", 
    "Antitrust law", 
    "Armed forces and national security", 
    "Arson", 
    "Biological warfare", 
    "Biological weapons", 
    "Biotechnology", 
    "Chemical warfare", 
    "Chemical weapons", 
    "Child health", 
    "Clinical trials", 
    "Commerce", 
    "Compensation for victims of crime", 
    "Crime and law enforcement", 
    "Damages", 
    "Department of Health and Human Services", 
    "Destruction of property", 
    "Drug approvals", 
    "Drug industry", 
    "Drug therapy", 
    "Drugs", 
    "EBB Terrorism", 
    "Education", 
    "Employee training", 
    "Environmental protection", 
    "Explosives", 
    "Factories", 
    "Families", 
    "Federal installations", 
    "Fines (Penalties)", 
    "Government and business", 
    "Government liability", 
    "Government operations and politics", 
    "Government paperwork", 
    "Government publicity", 
    "Health", 
    "Higher education", 
    "Human experimentation in medicine", 
    "Indemnity", 
    "International affairs", 
    "Interstate commerce", 
    "Joint ventures", 
    "Labor and employment", 
    "Laboratories", 
    "Laboratory animals", 
    "Law", 
    "Life imprisonment", 
    "Medical education", 
    "Medical research", 
    "Medical supplies", 
    "Medical technology", 
    "Military bases", 
    "Nuclear terrorism", 
    "Nuclear weapons", 
    "Pharmaceutical research", 
    "Preventive medicine", 
    "Product development", 
    "Protection of animals", 
    "Public-private partnerships", 
    "Radiation victims", 
    "Research and development contracts", 
    "Science, technology, communications", 
    "Security measures", 
    "Sentences (Criminal procedure)", 
    "State-sponsored terrorism", 
    "Storage", 
    "Terrorism", 
    "Transportation and public works", 
    "Transportation of hazardous substances", 
    "Vaccines"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-11-06", 
    "text": "Pathogen Research, Emergency Preparedness and Response Efforts Act of 2001 (PREPARE Act) - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to encourage the development and manufacture of new products or new uses for products which can identify, prevent, or treat chemical or biological agents. Permits a limited antitrust exemption for the cooperative efforts of the pharmaceutical, biotechnical, medical device, and research industries when working to develop and bring such countermeasure products to market.Authorizes the Secretary to enter into contracts and provide assistance for product development, including good manufacturing practices and facility security.Requires the Secretary to ensure that medical supplies from the National Pharmaceutical Stockpile are located in appropriate proximity to the site of special events.Amends the Federal Food, Drug, and Cosmetic Act to permit: (1) fast-track designation and priority review for unapproved countermeasure products; and (2) the use of animal trials for drugs useful against lethal or disabling agents.Requires the Secretary to: (1) prohibit the unauthorized transportation of chemical or biological agents; (2) establish and maintain a list of each biological agent and toxin potentially threatening to public health and another list of those agents and toxins potentially threatening to national security; and (3) establish safety procedures for the transfer of such agents and toxins.Requires the Secretaries of Health and Human Services and Defense to coordinate the creation of a government-owned, contractor-operated vaccine production facility on a military installation."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Pathogen Research, Emergency Preparedness and Response Efforts Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "PREPARE Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to ensure the prompt research, development, manufacture, and distribution of new life-saving drugs, biologics, and medical devices that prevent or mitigate the consequences of a chemical or biological bioterrorist attack, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:47:14-05:00"
}